Timothy P. Walbert - 05 Apr 2023 Form 3 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
Director
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
05 Apr 2023
Transactions value $
$0
Form type
3
Filing time
06 Apr 2023, 18:58:04 UTC
Previous filing
06 Jan 2023
Next filing
14 Jun 2023

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.